Skip to content

Comparative Effectiveness of Ultrasound and Paraffin Therapy in Patients With Carpal Tunnel Syndrome: A Randomized Trial

Comparative Effectiveness of Ultrasound and Paraffin Therapy in Patients With Carpal Tunnel Syndrome: A Randomized Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02278289
Enrollment
60
Registered
2014-10-29
Start date
2010-01-31
Completion date
2011-12-31
Last updated
2021-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carpal Tunnel Syndrome

Brief summary

The purpose of this study is to compare the efficacy of combining a wrist orthosis with either ultrasound therapy or paraffin bath therapy in treating carpal tunnel syndrome patients.

Detailed description

The purpose of this exploratory study is to compare the combination of a wrist orthosis with either ultrasound therapy or paraffin bath therapy in the treatment of carpal tunnel syndrome patients. We hypothesized that ultrasound therapy might be more effective than paraffin therapy because it provides both thermal and nonthermal effects.

Interventions

DEVICEultrasound

Patients in the ultrasound therapy group were treated with US therapy for 5 minutes each session, twice per week for 8 weeks.

PROCEDUREparaffin therapy

Patients in the paraffin therapy group were treated with the dip-and-wrap method of paraffin bath therapy in the hospital twice per week for 8 weeks. The temperature of the paraffin bath was maintained at approximately 55°C

Sponsors

National Science and Technology Council, Taiwan
CollaboratorOTHER_GOV
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients to have subjective symptoms (such as pain and/or numbness in the median nerve distribution of the digits or nocturnal pain). Furthermore, patients were required to have either a positive Phalen's sign or a positive Tinel's sign along with electrophysiological evidence of carpal tunnel syndrome.

Exclusion criteria

* (1) age younger than 18 years old; (2) underlying medical disorders, such as diabetes mellitus, renal failure, autoimmune disease or hypothyroidism; and (3) pregnancy, previous wrist trauma or surgery.

Design outcomes

Primary

MeasureTime frameDescription
Functional Status Scale of the Boston Carpal Tunnel Syndrome Questionnaire8 weeksAll of the answers were scored from 1 to 5 according to the patient's clinical condition, such that 1 indicated no symptoms, and 5 indicated the most severe symptoms.

Secondary

MeasureTime frameDescription
Pain Scale8 weeksThe pain VAS is a continuous scale comprised 10 centimeters (100 mm) in length. 0 indicate no pain, 100 indicate maximum pain.
Difference of Monofilament Sensory Test (Before and After Treatment)8 weeksThe Semmes-Weinstein monofilament sensory test was measured by applying force-calibrated nylon filament to the fingertips with the wrist in a neutral supine position A weighted score from 1 to 5 was acquired according to each filament's calculated force . We recorded the scores from seven sample areas in each hand and summed the scores to analyze as a continuous variable.Higher score indicate decreased finger tip sensation with increased disesase severity.Total score range:7 -35.
Symptom Severity Scale of the Boston Carpal Tunnel Syndrome Questionnaire8 weeksAll of the answers were scored from 1 to 5 according to the patient's clinical condition, such that 1 indicated no symptoms, and 5 indicated the most severe symptoms.
Difference in the Distal Sensory Latencies of the Median Nerve (Before and After Treatment)8 weeksA standard distance (14 centimeter) was maintained between the stimulator and recording electrodes for the sensory nerve conduction studies. Increased distal latency indicate delay of nerve conduction, which imply poor disease progress.
Difference in the Distal Motor Latencies of the Median Nerve (Before and After Treatment)8 weeksMedian motor nerve conduction and distal motor latency were measured by placing a stimulating electrode at the wrist and a recording electrode on the abductor pollicis brevis muscle 8 centimeter from the stimulus electrode. Increased distal latency indicate delay of nerve conduction, which imply poor disease progress.
Difference in Palmar Pinch Power Test (Before and After Treatment)8 weeksPalmar pinch strength was measured by pressing the thumb and the index finger tip against a standard dynamometer. This procedure was repeated 3 times measuring in kilograms, and a mean score was obtained. Higher score indicate better pinching strength, which indicate less disease severity. Score range: minimum :0 kilogram

Participant flow

Participants by arm

ArmCount
Ultrasound Therapy Group
Patients in the ultrasound therapy group were treated with US therapy for 5 minutes each session, twice per week for 8 weeks. ultrasound: Patients in the ultrasound therapy group were treated with US therapy for 5 minutes each session, twice per week for 8 weeks.
24
Paraffin Therapy Group
Patients in the paraffin therapy group were treated with the dip-and-wrap method of paraffin bath therapy in the hospital twice per week for 8 weeks. The temperature of the paraffin bath was maintained at approximately 55°C paraffin therapy: Patients in the paraffin therapy group were treated with the dip-and-wrap method of paraffin bath therapy in the hospital twice per week for 8 weeks. The temperature of the paraffin bath was maintained at approximately 55°C
23
Total47

Baseline characteristics

CharacteristicUltrasound Therapy GroupParaffin Therapy GroupTotal
Age, Continuous48.8 years
STANDARD_DEVIATION 11.2
51.9 years
STANDARD_DEVIATION 8.8
50.4 years
STANDARD_DEVIATION 10.1
Sex/Gender, Customized
Female
22 participants20 participants42 participants
Sex/Gender, Customized
Male
2 participants3 participants5 participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 240 / 23
serious
Total, serious adverse events
0 / 240 / 23

Outcome results

Primary

Functional Status Scale of the Boston Carpal Tunnel Syndrome Questionnaire

All of the answers were scored from 1 to 5 according to the patient's clinical condition, such that 1 indicated no symptoms, and 5 indicated the most severe symptoms.

Time frame: 8 weeks

ArmMeasureValue (MEAN)Dispersion
Ultrasound Therapy GroupFunctional Status Scale of the Boston Carpal Tunnel Syndrome Questionnaire1.6 units on a scaleStandard Deviation 0.7
Paraffin Therapy GroupFunctional Status Scale of the Boston Carpal Tunnel Syndrome Questionnaire1.8 units on a scaleStandard Deviation 0.9
Secondary

Difference in Palmar Pinch Power Test (Before and After Treatment)

Palmar pinch strength was measured by pressing the thumb and the index finger tip against a standard dynamometer. This procedure was repeated 3 times measuring in kilograms, and a mean score was obtained. Higher score indicate better pinching strength, which indicate less disease severity. Score range: minimum :0 kilogram

Time frame: 8 weeks

ArmMeasureValue (MEAN)Dispersion
Ultrasound Therapy GroupDifference in Palmar Pinch Power Test (Before and After Treatment)0.5 kilogramsStandard Deviation 1.4
Paraffin Therapy GroupDifference in Palmar Pinch Power Test (Before and After Treatment)0.4 kilogramsStandard Deviation 1.8
Secondary

Difference in the Distal Motor Latencies of the Median Nerve (Before and After Treatment)

Median motor nerve conduction and distal motor latency were measured by placing a stimulating electrode at the wrist and a recording electrode on the abductor pollicis brevis muscle 8 centimeter from the stimulus electrode. Increased distal latency indicate delay of nerve conduction, which imply poor disease progress.

Time frame: 8 weeks

ArmMeasureValue (MEAN)Dispersion
Ultrasound Therapy GroupDifference in the Distal Motor Latencies of the Median Nerve (Before and After Treatment)-0.03 millisecondsStandard Deviation 0.6
Paraffin Therapy GroupDifference in the Distal Motor Latencies of the Median Nerve (Before and After Treatment)-0.3 millisecondsStandard Deviation 0.6
Secondary

Difference in the Distal Sensory Latencies of the Median Nerve (Before and After Treatment)

A standard distance (14 centimeter) was maintained between the stimulator and recording electrodes for the sensory nerve conduction studies. Increased distal latency indicate delay of nerve conduction, which imply poor disease progress.

Time frame: 8 weeks

ArmMeasureValue (MEAN)Dispersion
Ultrasound Therapy GroupDifference in the Distal Sensory Latencies of the Median Nerve (Before and After Treatment)0.03 millisecondsStandard Deviation 1.1
Paraffin Therapy GroupDifference in the Distal Sensory Latencies of the Median Nerve (Before and After Treatment)-0.2 millisecondsStandard Deviation 0.9
Secondary

Difference of Monofilament Sensory Test (Before and After Treatment)

The Semmes-Weinstein monofilament sensory test was measured by applying force-calibrated nylon filament to the fingertips with the wrist in a neutral supine position A weighted score from 1 to 5 was acquired according to each filament's calculated force . We recorded the scores from seven sample areas in each hand and summed the scores to analyze as a continuous variable.Higher score indicate decreased finger tip sensation with increased disesase severity.Total score range:7 -35.

Time frame: 8 weeks

ArmMeasureValue (MEAN)Dispersion
Ultrasound Therapy GroupDifference of Monofilament Sensory Test (Before and After Treatment)1.2 units on a scaleStandard Deviation 3.3
Paraffin Therapy GroupDifference of Monofilament Sensory Test (Before and After Treatment)1.2 units on a scaleStandard Deviation 3.5
Secondary

Pain Scale

The pain VAS is a continuous scale comprised 10 centimeters (100 mm) in length. 0 indicate no pain, 100 indicate maximum pain.

Time frame: 8 weeks

ArmMeasureValue (MEAN)Dispersion
Ultrasound Therapy GroupPain Scale54.2 units on a scaleStandard Deviation 22.6
Paraffin Therapy GroupPain Scale50.7 units on a scaleStandard Deviation 22.7
Secondary

Symptom Severity Scale of the Boston Carpal Tunnel Syndrome Questionnaire

All of the answers were scored from 1 to 5 according to the patient's clinical condition, such that 1 indicated no symptoms, and 5 indicated the most severe symptoms.

Time frame: 8 weeks

ArmMeasureValue (MEAN)Dispersion
Ultrasound Therapy GroupSymptom Severity Scale of the Boston Carpal Tunnel Syndrome Questionnaire2.1 units on a scaleStandard Deviation 0.8
Paraffin Therapy GroupSymptom Severity Scale of the Boston Carpal Tunnel Syndrome Questionnaire1.9 units on a scaleStandard Deviation 0.7

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026